Facebook Pixel

2 More Studies Link Bayer Heart Drug To Deaths

Rate This

ATLANTA - Heart surgery patients were more likely to die if given the anti-bleeding drug Trasylol, two more U.S. studies have found, renewing the claims that the drug is dangerous.

Bayer AG stopped selling the drug last fall, after a Canadian study was halted because of deaths among patients taking Trasylol.

But the new research reignited controversy over Trasylol, which was on the market for 14 years and used by doctors to treat hundreds of thousands of heart bypass patients each year.


Add a CommentComments

There are no comments yet. Be the first one and get the conversation started!

Enter the characters shown in the image.
By submitting this form, you agree to EmpowHER's terms of service and privacy policy

Heart Attack

Get Email Updates

Heart Attack Guide

Have a question? We're here to help. Ask the Community.


Health Newsletter

Receive the latest and greatest in women's health and wellness from EmpowHER - for free!